Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
National Cancer Institute (NCI)
AstraZeneca
Genmab
Seagen Inc.
Dana-Farber Cancer Institute
Mayo Clinic
BioNTech SE
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Psyence Australia Pty Ltd
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Erasca, Inc.
Ipsen
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
Pfizer
University of Florida
Arvinas Inc.
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
Genentech, Inc.
OHSU Knight Cancer Institute
MacroGenics
St. Jude Children's Research Hospital
DualityBio Inc.
MacroGenics
Indiana University
City of Hope Medical Center
Daiichi Sankyo
Beijing Tide Pharmaceutical Co., Ltd
IDEAYA Biosciences
Conjupro Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Pfizer
Second Life Therapeutics
ImmunityBio, Inc.
AgonOx, Inc.
Innate Pharma
Novartis
City of Hope Medical Center
Amgen